By Valerie Bauman
That doesn’t mean that the Democratic presidential candidates shouldn’t pursue that approach, said Peter Maybarduk, director of Access to Medicines for nonprofit Public Citizen.
“It’s a much needed development for political leaders to recognize monopoly power as the root problem of high drug prices,” he said. “Greed is out of control, so our elected leaders have to have better answers now.”
Read the full article here.